INVESTOR ALERT: Investigation of aTyr Pharma, Inc. (ATYR) Announced by Holzer & Holzer, LLC
aTyr Pharma, Inc.(US:ATYR) Globenewswire·2025-09-16 18:03ATLANTA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) complied with federal securities laws. On September 15, 2025, aTyr announced topline results from its Phase 3 EFZO-FIT study, which “did not meet its primary endpoint of change from baseline in mean daily oral corticosteroid (“OCS”) dose at week 48.” Following this news, the price of the Company’s stock declined. If you purchased aTyr stock and suffered a loss ...